PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,991 stories, page 409 of 684

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Suspends FSSAI Licence Of Fort's Poornima Restaurant Over Fungal Food and Hygiene Violations

lokmattimes.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Boston Scientific unveils major restructuring, plots job cuts amid savings drive

Fierce BiotechOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Botulism: clinical and public health management

Information for healthcare professionals on the diagnosis and treatment of infant botulism, foodborn...

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Vanguard Health Care ETF Outperforms VanEck Biotech on Returns, Yield, and Fees

The Motley FoolOriginal source
🇩🇪Researchuni-heidelberg.deTier 2 · Direct publisher

4EU+ European University Alliance Goes into Third Funding Period

Heidelberg UniversityOriginal source
🌍Medianovartis.comTier 3 · Secondary coverage

Smarter decisions at scale: How Novartis is using AI to advance R&D

NovartisOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Bioscience and health technology sector statistics 2024 to 2025

Official statistics in development estimating the size and composition of the life sciences sector i...

UK Department of Health and Social CareOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

EU governments set to address biotech and economic security

Research Professional NewsOriginal source
🌍Industryrelmada.comTier 1 · Company source

Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer

Relmada TherapeuticsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Oak Hill Bio Announces Dosing of First Participant in BEACON Phase 3 Clinical Trial of Rugonersen in Angelman Syndrome

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Dasher Neuroscience Completes Patient Enrollment in Phase 2 Global Clinical Trial of Lead AI Drug Candidate YA-101 for Multiple System Atrophy (MSA)

PR NewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Chip Parkinson on Direct-to-Patient's Big Year

Pharmaceutical CommerceOriginal source
🇺🇰Industrygsk.comTier 1 · Company source

GSK to establish new flagship R&D centre on Cambridge Biomedical Campus, UK

GSK NewsOriginal source
🇺🇸Devicesapyxmedical.comTier 1 · Company source

Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference

Apyx MedicalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Five-Gate Framework Proposed for India-UK Pharmaceutical Trade Agreement Implementation

geneonline.comOriginal source
🇺🇰Industrygsk.comTier 1 · Company source

GSK delivers strong Q2 core results performance and continued momentum. Plans announced to accelerate R&D and late-stage pipeline portfolio. Expect 20+ phase III trial starts in 2026

GSK NewsOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Oxygen 100%: Gas cylinders containing commercial grade oxygen

Gas cylinders containing industrial grade oxygen were delivered instead of medical grade oxygen.

Health Canada Recalls and Safety AlertsOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

IQecg® Digital ECG

Affected IQecg® plugin software may produce incorrect ECG waveforms and inaccurate heart-rate calcul...

Health Canada Recalls and Safety AlertsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

A webcast will carry Legend Biotech's Q2 results review Aug. 11

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Legend Biotech to Host Investor Conference Call on Second Quarter 2026 Results

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Oak Hill Bio Announces Dosing of First Participant in

GlobeNewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Trevi Therapeutics to present at August biotech conferences on its chronic cough therapy Haduvio™

PluangOriginal source
🌍Mediaheartsciences.comTier 2 · Direct publisher

Fortitude Energizes 12 MW Grand Island, Nebraska Facility, Expanding Owned-and-Operated Power Portfolio

HeartSciencesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Jordanian Pharmaceutical Manufacturing Q2 Profit 1.9 Million Dinars

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'grady As Chief Executive Officer To Lead Strategic Growth

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

GSK beats consensus forecast in second quarter

medwatch.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

H.C. Wainwright reiterates Buy on Legend Biotech stock, $65 target

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth

marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries Ltd. $TEVA is Rubric Capital Management LP's 4th Largest Position

MarketBeatOriginal source
🇺🇰Researchmedsci.ox.ac.ukTier 2 · Direct publisher

Tommy’s National Centre for Miscarriage Research celebrates ten years of progress

Oxford MedicineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Grace Therapeutics Says FDA Minutes Confirm No Clinical Safety or Efficacy Deficiencies in GTx-104 Review, Advances Dual-Source Manufacturing Plan Toward NDA Resubmission

Quiver QuantitativeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Atea Pharmaceuticals Reports Positive Phase 3 C-BEYOND Results for Bemnifosbuvir/Ruzasvir in Hepatitis C, Achieving Non-Inferiority to Epclusa

Quiver QuantitativeOriginal source
🇺🇰Researchmedsci.ox.ac.ukTier 2 · Direct publisher

Trial exploring effects of drug on liver in psoriasis patients recruits first UK patient

Oxford MedicineOriginal source
🇺🇰Industrygsk.comTier 1 · Company source

GSK’s licensor Hansoh Pharma announces positive results from a second phase III trial for Ris-Rez in China

GSK NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Atea's 8-week hepatitis C regimen posts 93.5% cure rate

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Grace Therapeutics Advances Second U.S. Manufacturing Route for GTx-104

Stock TitanOriginal source
🇺🇸Devicesir.idexx.comTier 1 · Company source

IDEXX Releases 2025 Corporate Responsibility Report, Highlighting Progress Against Its Goals

IDEXX LaboratoriesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Insiders In Kane Biotech Still Down 40% On CA$1.70m Investment

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sihuan Pharmaceutical Holdings Group (SEHK:460) Looks Pricey On 2026 Earnings Guidance

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

China's biotech rise to face challenges from US policy responses

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Singapore: HST Medical acquired by Kowa Pharmaceutical Asia to scale health brands globally

Investors in HealthcareOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Preliminary trial results suggest a path to a safer Alzheimer’s treatment

STATOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Integrated care pathway in individuals with Long COVID: STIMULATE-ICP, a cluster-randomized, phase 3 trial

NatureOriginal source
🇩🇪Researchuni-heidelberg.deTier 2 · Direct publisher

The University Celebrates with Visitors from all Over the World

Heidelberg UniversityOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

SBI Securities Starts Takeda Pharmaceutical at Neutral with 5,400 Yen Price Target

marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Parkinson’s Disease Drug Trial Extended Following Early Findings

Technology NetworksOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

HLB PEP registers antidiuretic hormone treatment ‘Vasopressin’ API with U.S. FDA

더바이오Original source
🌍Industrysinopharmtech.comTier 1 · Company source

SinoPharmtech at the “Vysokiy Bereg 2026” Tourism Rally in Belarus

Sinopharm TechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships

Macau BusinessOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech Growth makes 14-times return on Forte Biosciences accepting $2.2bn bid from Argenx SE

QuotedDataOriginal source
🇮🇹Researchhumanitas.itTier 2 · Direct publisher

Onde d’urto focali: applicazioni e benefici in ortopedia e riabilitazione

Humanitas Research HospitalOriginal source
🌍discoverynews.google.comTier 2 · Trade media

From ‘lost cause’ to gold rush: Biotechs swarm to cure AATD

STATOriginal source
🌍Researchamref.orgTier 2 · Direct publisher

Feasibility of mainstreaming schistosomiasis and soil transmitted helminthiasis mass drug administration into primary healthcare: a baseline survey for a community case study in Western Kenya

Amref Health AfricaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Kelun-Biotech receives trial notice for dual-payload ADC

Vietnam Investment Review - VIROriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Apnimed prepares IPO as Mass. biotechs near record year

The Business JournalsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Hanmi Pharmaceutical posts Q2 profit surge on Lilly deal and strong Korea sales - CHOSUNBIZ

ChosunbizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Hanmi Pharmaceutical Q2 Operating Profit Surges 116.9%

조선일보Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Poornima Restaurant, Iconic Fort Udupi Eatery, Loses Food Licence After Maharashtra FDA Finds Serious

LatestLYOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Gerresheimer doubles China injectable packaging capacity with new plant

Packaging InsightsOriginal source